{"id":774988,"date":"2023-08-03T07:36:32","date_gmt":"2023-08-03T11:36:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/"},"modified":"2023-08-03T07:36:32","modified_gmt":"2023-08-03T11:36:32","slug":"affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/","title":{"rendered":"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023"},"content":{"rendered":"
\n

HEIDELBERG, Germany, Aug. 03, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release second quarter 2023 results and corporate update on Thursday, August 10, 2023. The Company will host a conference call at 8:30 a.m. EDT \/ 14:30 CET.<\/p>\n

The conference call will be available via phone and webcast. The live audio webcast of the call will be available in the \u201cWebcasts\u201d section on the \u201cInvestors\u201d page of the Affimed website at\u00a0https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/<\/a>. To access the call by phone, please use link\u00a0https:\/\/register.vevent.com\/register\/BI1a95f0d05ae14e099ffc1c7872731338<\/a>, and you will be provided with dial-in details and a pin number.<\/p>\n

\n Note:<\/strong> To avoid delays, we encourage participants to dial into the conference call 15 minutes ahead of the scheduled start time. A replay of the webcast will be accessible at the same link for 30 days following the call.<\/p>\n

\n About Affimed N.V.<\/strong>
\n
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The Company\u2019s proprietary ROCK\u00ae<\/sup> platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK\u00ae<\/sup> platform predictably generates customized innate cell engager (ICE\u00ae<\/sup>) molecules, which use patients\u2019 immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE\u00ae<\/sup>. Headquartered in Heidelberg, Germany, with offices in New York, NY, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients\u2019 lives. For more about the Company\u2019s people, pipeline and partners, please visit: www.affimed.com<\/a>.<\/p>\n

\n Investor Relations Contact<\/strong>
\n
Alexander Fudukidis
Director, Head of Investor Relations
E-Mail: a.fudukidis@affimed.com<\/a>
Tel.: +1 (917) 436-8102<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

HEIDELBERG, Germany, Aug. 03, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release second quarter 2023 results and corporate update on Thursday, August 10, 2023. The Company will host a conference call at 8:30 a.m. EDT \/ 14:30 CET. The conference call will be available via phone and webcast. The live audio webcast of the call will be available in the \u201cWebcasts\u201d section on the \u201cInvestors\u201d page of the Affimed website at\u00a0https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. To access the call by phone, please use link\u00a0https:\/\/register.vevent.com\/register\/BI1a95f0d05ae14e099ffc1c7872731338, and you will be provided with dial-in details and a pin number. Note: To avoid delays, we encourage participants … <\/p>\n

Continue reading “Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-774988","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAffimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HEIDELBERG, Germany, Aug. 03, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release second quarter 2023 results and corporate update on Thursday, August 10, 2023. The Company will host a conference call at 8:30 a.m. EDT \/ 14:30 CET. The conference call will be available via phone and webcast. The live audio webcast of the call will be available in the \u201cWebcasts\u201d section on the \u201cInvestors\u201d page of the Affimed website at\u00a0https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. To access the call by phone, please use link\u00a0https:\/\/register.vevent.com\/register\/BI1a95f0d05ae14e099ffc1c7872731338, and you will be provided with dial-in details and a pin number. Note: To avoid delays, we encourage participants … Continue reading "Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T11:36:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023\",\"datePublished\":\"2023-08-03T11:36:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/\"},\"wordCount\":342,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/\",\"name\":\"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=\",\"datePublished\":\"2023-08-03T11:36:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/","og_locale":"en_US","og_type":"article","og_title":"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023 - Market Newsdesk","og_description":"HEIDELBERG, Germany, Aug. 03, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release second quarter 2023 results and corporate update on Thursday, August 10, 2023. The Company will host a conference call at 8:30 a.m. EDT \/ 14:30 CET. The conference call will be available via phone and webcast. The live audio webcast of the call will be available in the \u201cWebcasts\u201d section on the \u201cInvestors\u201d page of the Affimed website at\u00a0https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. To access the call by phone, please use link\u00a0https:\/\/register.vevent.com\/register\/BI1a95f0d05ae14e099ffc1c7872731338, and you will be provided with dial-in details and a pin number. Note: To avoid delays, we encourage participants … Continue reading \"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-03T11:36:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023","datePublished":"2023-08-03T11:36:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/"},"wordCount":342,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/","name":"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=","datePublished":"2023-08-03T11:36:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTg4MSM1NzMzMzM5IzIwMDM3MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-second-quarter-2023-financial-results-corporate-update-on-august-10-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Affimed to Report Second Quarter 2023 Financial Results &\u00a0Corporate Update on August 10, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=774988"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774988\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=774988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=774988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=774988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}